119 related articles for article (PubMed ID: 11504364)
1. Evaluation of the prognostic accuracy of Astler-Coller's and Jass' classifications of colorectal cancer.
Li Destri G; Rinzivillo C; Vasquez E; Di Cataldo A; Puleo S; Licata A
Tumori; 2001; 87(3):127-9. PubMed ID: 11504364
[TBL] [Abstract][Full Text] [Related]
2. [New prognostic parameters and categories of colorectal carcinoma--correlation with standards].
Micev M; Cosić-Micev M; Krivokapić Z; Marković V; Popović M
Acta Chir Iugosl; 1998; 45(2 Suppl):61-8. PubMed ID: 10951790
[TBL] [Abstract][Full Text] [Related]
3. Jass' classification revisited.
Deans GT; Heatley M; Anderson N; Patterson CC; Rowlands BJ; Parks TG; Spence RA
J Am Coll Surg; 1994 Jul; 179(1):11-7. PubMed ID: 8019715
[TBL] [Abstract][Full Text] [Related]
4. Jass staging is a predictor of outcome following "curative" resection of Dukes' B colorectal carcinoma.
Mander BJ; Carney LJ; Scott HJ; Donaldson DR
Surgeon; 2006 Aug; 4(4):227-30. PubMed ID: 16892840
[TBL] [Abstract][Full Text] [Related]
5. Cyclin/proliferation cell nuclear antigen immunohistochemistry does not improve the prognostic power of Dukes' or Jass' classifications for colorectal cancer.
Neoptolemos JP; Oates GD; Newbold KM; Robson AM; McConkey C; Powell J
Br J Surg; 1995 Feb; 82(2):184-7. PubMed ID: 7749683
[TBL] [Abstract][Full Text] [Related]
6. Lymph node ratio improves TNM and Astler-Coller's assessment of colorectal cancer prognosis: an analysis of 761 node positive cases.
Costi R; Beggi F; Reggiani V; Riccò M; Crafa P; Bersanelli M; Tartamella F; Violi V; Roncoroni L; Sarli L
J Gastrointest Surg; 2014 Oct; 18(10):1824-36. PubMed ID: 25091835
[TBL] [Abstract][Full Text] [Related]
7. Prognosis in Duke's B colorectal carcinoma: the Jass classification revisited.
De Quay N; Cerottini JP; Albe X; Saraga E; Givel JC; Caplin S
Eur J Surg; 1999 Jun; 165(6):588-92. PubMed ID: 10433145
[TBL] [Abstract][Full Text] [Related]
8. [The prognostic value of Jass' histopathological classification of cancer of the left colon and rectum].
Secco GB; Fardelli R; Lapertosa G; Fulcheri E; Rovida S; Ratto GB; Prior C
Minerva Chir; 1990 Nov; 45(21-22):1347-53. PubMed ID: 2097559
[TBL] [Abstract][Full Text] [Related]
9. Validation of a new classification system for curatively resected colorectal adenocarcinoma.
Sternberg A; Sibirsky O; Cohen D; Blumenson LE; Petrelli NJ
Cancer; 1999 Sep; 86(5):782-92. PubMed ID: 10463976
[TBL] [Abstract][Full Text] [Related]
10. Accurate lymph-node detection in colorectal specimens resected for cancer is of prognostic significance.
Ratto C; Sofo L; Ippoliti M; Merico M; Bossola M; Vecchio FM; Doglietto GB; Crucitti F
Dis Colon Rectum; 1999 Feb; 42(2):143-54; discussion 154-8. PubMed ID: 10211489
[TBL] [Abstract][Full Text] [Related]
11. Dukes's classification: a valid prognostic indicator for gastric cancer.
Adachi Y; Mori M; Maehara Y; Sugimachi K
Gut; 1994 Oct; 35(10):1368-71. PubMed ID: 7959188
[TBL] [Abstract][Full Text] [Related]
12. Dukes' classification revisited. Findings from the National Surgical Adjuvant Breast and Bowel Projects (Protocol R-01).
Fisher ER; Sass R; Palekar A; Fisher B; Wolmark N
Cancer; 1989 Dec; 64(11):2354-60. PubMed ID: 2804927
[TBL] [Abstract][Full Text] [Related]
13. Jass' classification revisited.
Jass JR
J Am Coll Surg; 1995 Feb; 180(2):252-3. PubMed ID: 7850066
[No Abstract] [Full Text] [Related]
14. Tumour recurrence is associated with Jass grouping but not with differences in E-cadherin expression in moderately differentiated Dukes' B colorectal cancers.
Ilyas M; Novelli M; Wilkinson K; Tomlinson IP; Abbasi AM; Forbes A; Talbot IC
J Clin Pathol; 1997 Mar; 50(3):218-22. PubMed ID: 9155672
[TBL] [Abstract][Full Text] [Related]
15. [The recurrence of colorectal cancer and blood transfusion].
Elorza Orúe JL; Palomar de Luis M; Tubía Landaberea J
Rev Esp Enferm Dig; 1992 Sep; 82(3):150-3. PubMed ID: 1419311
[TBL] [Abstract][Full Text] [Related]
16. Expression of p21WAF1 in Astler-Coller stage B2 colorectal cancer is associated with survival benefit from 5FU-based adjuvant chemotherapy.
Sulzyc-Bielicka V; Domagala P; Urasinska E; Bielicki D; Safranow K; Domagala W
Virchows Arch; 2011 Apr; 458(4):431-8. PubMed ID: 21369800
[TBL] [Abstract][Full Text] [Related]
17. [Histopathological finding as a prognostic factor of the surgical treatment outcome in colorectal cancer].
Secen S; Moljević N; Vuković M; Somer L
Vojnosanit Pregl; 2010 Aug; 67(8):638-43. PubMed ID: 20845666
[TBL] [Abstract][Full Text] [Related]
18. Tumor growth pattern and thymidine phosphorylase expression are related with the risk of hematogenous metastasis in patients with Astler Coller B1/B2 colorectal carcinoma.
van Halteren HK; Peters HM; van Krieken JH; Coebergh JW; Roumen RM; van der Worp E; Wagener JT; Vreugdenhil G
Cancer; 2001 May; 91(9):1752-7. PubMed ID: 11335901
[TBL] [Abstract][Full Text] [Related]
19. Relative prognostic value of the Dukes and the Jass systems in rectal cancer. Findings from the National Surgical Adjuvant Breast and Bowel Projects (Protocol R-01).
Fisher ER; Robinsky B; Sass R; Fisher B
Dis Colon Rectum; 1989 Nov; 32(11):944-9. PubMed ID: 2478350
[TBL] [Abstract][Full Text] [Related]
20. The role of venous and neural invasion on survival in rectal adenocarcinoma.
Horn A; Dahl O; Morild I
Dis Colon Rectum; 1990 Jul; 33(7):598-601. PubMed ID: 2361429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
